Attached files

file filename
EX-31.1 - EXHIBIT 31.1 - AYTU BIOPHARMA, INCv465720_ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - AYTU BIOPHARMA, INCv465720_ex31-2.htm
EX-10.1 - EXHIBIT 10.1 - AYTU BIOPHARMA, INCv465720_ex10-1.htm
10-Q - 10-Q - AYTU BIOPHARMA, INCv465720_10q.htm


Exhibit 32.1




Certification Pursuant to 18 U.S.C. Section 1350, as Adopted


Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


In connection with the filing of the quarterly report on Form 10-Q for the quarter ended March 31, 2017 (the “Report”) by Aytu BioScience, Inc. (the “Company”), each of the undersigned hereby certifies that:


1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and


2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: May 11, 2017 /s/ Joshua R. Disbrow
  Joshua R. Disbrow
  Chief Executive Officer
Dated: May 11, 2017 /s/ Gregory A. Gould
  Gregory A. Gould
  Chief Financial Officer